Nicotinic receptors modulate antitumor therapy response in triple negative breast cancer cells

Table 1 Effect of the combination of paclitaxel with nicotine on MDA-MB-468 and MCF-7 cell viability

Treatment	MDA-MB-468, cell viability (% of control)	MCF-7, cell viability (% of control)
PX	61.01 ± 3.79	65.36 ± 4.86
NIC	137.79 ± 3.69c	141.94 ± 4.07c
PX+NIC	79.15 ± 6.94a	117.99 ± 10.06c
PX+NIC+MM	62.37 ± 4.71	69.13 ± 7.22

^aP < 0.05 vs control.

^cP < 0.001 vs control.